Story thread · 3 reports / 1 sources
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem
finance.yahoo.com · 3d
How the coverage leans
Across 1 sources · syndicated copies counted once
First report: How Novo Nordisk’s CEO Says He Is Shifting the Company’s Perspective — finance.yahoo.com, 5d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.